Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alan Bakst"'
Publikováno v:
Quality of Life Research. 14:329-347
Background: The impact of acute exacerbations of chronic bronchitis (AECB), a common consequence of chronic obstructive pulmonary disease (COPD), is extensive, with symptoms ranging from mild to life threatening. Health-related quality of life (HRQL)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c36cdc1ade763b560eb15fcb4c84f4
https://doi.org/10.1007/s11136-004-0625-1
https://doi.org/10.1007/s11136-004-0625-1
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 1:249-254
Acute exacerbations of chronic bronchitis (AECB) are known to have a substantial economic burden in terms of medical care costs. The objective of this study was to assess workplace-based costs associated with AECB, including absenteeism and decreased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52b21f29d65c8d053dcaac4a1608c86
https://doi.org/10.1081/copd-120039211
https://doi.org/10.1081/copd-120039211
Autor:
Joseph Jackson, Jon Clouse, James G. Kotsanos, Katie Copley-Merriman, Joel W. Hay, Rod Barnes, Patricia Deverka, Renee Goldberg Arnold, Gordon J. Vanscoy, Marilyn Dix Smith, Alan Heaton, Alan Bakst, Margaret Healey, Jean Paul Gagnon, Elaine Power, Donna Rindress
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2(2)
1 Hoechst Marion Roussel, Inc., Kansas City, MO, 2 International Society for Pharmacoeconomics and Outcomes Research, Princeton, NJ, 3 BioMedCom Consultants inc., Montreal, Canada, 4 The Institute for Research & Education, HealthSystems Minnesota, Mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9e747c95716dbf8d29a436bdfe80847
https://pubmed.ncbi.nlm.nih.gov/16674335
https://pubmed.ncbi.nlm.nih.gov/16674335
Autor:
William H, Herman, Riad G, Dirani, Ruslan, Horblyuk, M Colleen, O'Neill, Barbara, Kravitz, Mark A, Heise, Alan, Bakst, Martin I, Freed
Publikováno v:
The American journal of managed care. 11(4)
To assess and compare healthcare utilization and costs over a 2-year period in older patients (or = 60 years) with type 2 diabetes receiving combination therapy with rosiglitazone plus a sulfonylurea (glipizide) or progressive up-titration of glipizi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c3222fefb1082b7c18645037a3ef82c
https://pubmed.ncbi.nlm.nih.gov/15839187
https://pubmed.ncbi.nlm.nih.gov/15839187
Publikováno v:
Journal of managed care pharmacy : JMCP. 9(4)
BACKGROUND: Acute exacerbations of chronic bronchitis (AECB) are recurrent and potentially severe medical events for the 13 million people in the United States who have chronic bronchitis. Medical resource use associated with AECB can have a substant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637ed5d7d6bb32427ed068e591da0f22
https://pubmed.ncbi.nlm.nih.gov/14613454
https://pubmed.ncbi.nlm.nih.gov/14613454
Autor:
Ohad Amit, Jeffrey Edelson, Gerhard Schultze-Werninghaus, Chris Compton, Neil Barnes, Richard Nieman, Jacques Phm Creemers, Jon G Ayres, Christian Brambilla, Jason Gubb, Alan Bakst
Publikováno v:
Lancet (London, England). 358(9278)
Chronic obstructive pulmonary disease (COPD) is a common, progressive respiratory disease that causes great morbidity and mortality despite treatment. There is evidence for airway inflammation in COPD. Cilomilast is an orally active, potent, selectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ddd3177764c43e10269032288d918c
https://pubmed.ncbi.nlm.nih.gov/11498207
https://pubmed.ncbi.nlm.nih.gov/11498207
Publikováno v:
International journal of technology assessment in health care. 16(1)
Objectives: Calculations of healthcare costs rarely disclose the specific approach used to allocate the cost of hospitalizations by diagnosis. However, the type of approach used can have a major impact on the findings in the case of significant comor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ceab3568354c9bd859b41335fdc821a
https://pubmed.ncbi.nlm.nih.gov/10815359
https://pubmed.ncbi.nlm.nih.gov/10815359
Publikováno v:
Journal of Urology. 177:68-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3871603850950e9e897531dc5a91ccde
https://doi.org/10.1016/s0022-5347(18)30469-5
https://doi.org/10.1016/s0022-5347(18)30469-5
Publikováno v:
Journal of Urology. 177:69-69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::011ea2ce963e42310f463103f05c327a
https://doi.org/10.1016/s0022-5347(18)30470-1
https://doi.org/10.1016/s0022-5347(18)30470-1
Autor:
Gloria Governali, Lisa Sanchez, Lorne E. Basskin, Alan Bakst, Jane T. Osterhaus, Eduardo Ortiz, Elaine Power, Laurie B. Burke
Publikováno v:
Value in Health. (2):103-106
• identify and prioritize key issues; • describe the mechanisms for putting pharmacoeconomic and outcomes information and data into the same operational format that decisionmakers use to make formulary decisions; • identify the entities that ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab08adb49ba12bec76fdc2c734efecf8